Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M H Huls

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Journal of Cellular Physiology|January 1, 1991
Characterization of atrial natriuretic peptide receptors in brain microvessel endothelial cellsP A Whitson, M H Huls, C F Sams
Cancer Gene Therapy|January 17, 2015
Manufacture of T cells using the Sleeping Beauty system to enforce expression of a CD19-specific chimeric antigen receptorH Singh, J S E Moyes, M H Huls, et al.
Journal of Cellular Physiology|July 1, 1989
Dexamethasone effects on creatine kinase activity and insulin-like growth factor receptors in cultured muscle cellsP A Whitson, C A Stuart, M H Huls, et al.
Blood|February 9, 2000
CD20 monoclonal antibody (rituximab) for therapy of Epstein-Barr virus lymphoma after hemopoietic stem-cell transplantationI Kuehnle, M H Huls, Z Liu, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|June 1, 2006
Slc11a1 (formerly Nramp1) polymorphisms and susceptibility to post-transplant lymphoproliferative disease following pediatric liver transplantationN R Barshes, T R Lee, J A Goss, et al.
Annals of the New York Academy of Sciences|February 8, 2006
T-cell immunotherapy for adenoviral infections of stem-cell transplant recipientsA M Leen, G D Myers, C M Bollard, et al.
Transplantation|October 2, 2001
Generation of autologous Epstein-Barr virus-specific cytotoxic T cells for adoptive immunotherapy in solid organ transplant recipientsB Savoldo, J Goss, Z Liu, et al.
Cytotherapy|July 10, 2003
Expansion of EBV latent membrane protein 2a specific cytotoxic T cells for the adoptive immunotherapy of EBV latency type 2 malignancies: influence of recombinant IL12 and IL15H-J Wagner, U Sili, B Gahn, et al.
Annals of Hematology|March 4, 2003
Immunotherapy for Hodgkin's diseaseC M Rooney, C Bollard, M H Huls, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Journal of Cellular Physiology|January 1, 1991
Characterization of atrial natriuretic peptide receptors in brain microvessel endothelial cellsP A Whitson, M H Huls, C F Sams
Cancer Gene Therapy|January 17, 2015
Manufacture of T cells using the Sleeping Beauty system to enforce expression of a CD19-specific chimeric antigen receptorH Singh, J S E Moyes, M H Huls, et al.
Journal of Cellular Physiology|July 1, 1989
Dexamethasone effects on creatine kinase activity and insulin-like growth factor receptors in cultured muscle cellsP A Whitson, C A Stuart, M H Huls, et al.
Blood|February 9, 2000
CD20 monoclonal antibody (rituximab) for therapy of Epstein-Barr virus lymphoma after hemopoietic stem-cell transplantationI Kuehnle, M H Huls, Z Liu, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|June 1, 2006
Slc11a1 (formerly Nramp1) polymorphisms and susceptibility to post-transplant lymphoproliferative disease following pediatric liver transplantationN R Barshes, T R Lee, J A Goss, et al.
Annals of the New York Academy of Sciences|February 8, 2006
T-cell immunotherapy for adenoviral infections of stem-cell transplant recipientsA M Leen, G D Myers, C M Bollard, et al.
Transplantation|October 2, 2001
Generation of autologous Epstein-Barr virus-specific cytotoxic T cells for adoptive immunotherapy in solid organ transplant recipientsB Savoldo, J Goss, Z Liu, et al.
Cytotherapy|July 10, 2003
Expansion of EBV latent membrane protein 2a specific cytotoxic T cells for the adoptive immunotherapy of EBV latency type 2 malignancies: influence of recombinant IL12 and IL15H-J Wagner, U Sili, B Gahn, et al.
Annals of Hematology|March 4, 2003
Immunotherapy for Hodgkin's diseaseC M Rooney, C Bollard, M H Huls, et al.
Pageof 1